Rosiglitazone alleviates LPS-induced endometritis via suppression of TLR4-mediated NF-κB activation
Fig 5
The effects of RGZ on the cell viability of HESCs.
Cells were treated with the indicated concentration of RGZ (0~40 μM/L) for 24 h, and the cell viability was assessed by CCK-8 kits. #P < 0.05 compared with control group.